Trade

with

Organovo Holdings Inc
(Amex: ONVO)
AdChoices
5.91
+0.05
+0.85%
After Hours :
5.91
0.00
0.00%

Open

5.92

Previous Close

5.86

Volume (Avg)

487.71k (1.02M)

Day's Range

5.83-6.01

52Wk Range

5.12-13.65

Market Cap.

463.82M

Dividend Rate ( Yield )

-

Beta

-0.20

Shares Outstanding

78.48M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 379.00k

    • Net Income

    • -25.85M

    • Market Cap.

    • 463.82M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -7,663.98

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -0.20

    • Forward P/E

    • -

    • Price/Sales

    • 1,250.00

    • Price/Book Value

    • 10.58

    • Price/Cash flow

    • -27.55

      • EBITDA

      • -25.45M

      • Return on Capital %

      • -92.84

      • Return on Equity %

      • -112.41

      • Return on Assets %

      • -92.84

      • Book Value/Share

      • 0.56

      • Shares Outstanding

      • 78.48M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -6.60

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 42.70

            • Pre-Tax Margin

            • -7,663.98

            • 11.63

            • Net Profit Margin

            • -7,663.98

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.00

              • 0.62

              • Current Ratio

              • 14.83

              • 1.23

              • Quick Ratio

              • 14.57

              • 0.76

              • Interest Coverage

              • -

              • 5.98

              • Leverage Ratio

              • 1.07

              • 2.16

              • Book Value/Share

              • 0.56

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -15.72

                • 33.22

                • P/E Ratio 5-Year High

                • -36.63

                • 325.07

                • P/E Ratio 5-Year Low

                • -3.33

                • 154.73

                • Price/Sales Ratio

                • 1,250.00

                • 2.34

                • Price/Book Value

                • 10.49

                • 3.04

                • Price/Cash Flow Ratio

                • -27.55

                • 19.08

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -112.41

                    (-)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • -92.84

                    (-)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • -112.33

                    (-)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • -

                  • 17.17k

                  • Inventory Turnover

                  • -

                  • 5.07

                  • Asset Turnover

                  • 0.01

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -20.65M
                  Operating Margin
                  -5,448.28
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -27.55
                  Ownership

                  Institutional Ownership

                  20.51%

                  Top 10 Institutions

                  13.90%

                  Mutual Fund Ownership

                  11.78%

                  Float

                  90.28%

                  5% / Insider Ownership

                  19.06%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • SPDR® S&P Biotech ETF

                  •  

                    2,136,149

                  • -1.92

                  • 2.50

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    1,402,617

                  • 0.00

                  • 1.79

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,015,835

                  • 0.00

                  • 1.29

                  • iShares Russell 2000 (AU)

                  •  

                    936,574

                  • -1.46

                  • 1.10

                  • Vanguard Extended Market Index Fund

                  •  

                    588,572

                  • 7.79

                  • 0.75

                  • iShares Russell 2000 Growth

                  •  

                    440,056

                  • 0.34

                  • 0.52

                  • Rydex Series Trust Biotechnology Fund

                  •  

                    320,180

                  • 0.00

                  • 0.41

                  • Fidelity Advisor® Biotechnology Fund

                  •  

                    244,983

                  • 0.00

                  • 0.31

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    201,943

                  • 0.00

                  • 0.26

                  • CREF Stock

                  •  

                    184,209

                  • 0.00

                  • 0.23

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • State Street Corp

                  •  

                    2,773,501

                  • +34.17%

                  • 3.54

                  • Vanguard Group, Inc.

                  •  

                    1,853,607

                  • +5.90%

                  • 2.37

                  • Fidelity Management and Research Company

                  •  

                    1,647,600

                  • -17.54%

                  • 2.10

                  • BlackRock Fund Advisors

                  •  

                    1,541,882

                  • +59,547.27%

                  • 1.97

                  • Goldman, Sachs & Co.

                  •  

                    762,143

                  • +104.03%

                  • 0.97

                  • UBS Securities LLC

                  •  

                    596,031

                  • -40.61%

                  • 0.76

                  • Morgan Stanley Smith Barney LLC

                  •  

                    568,843

                  • -7.08%

                  • 0.73

                  • Security Investors, LLC

                  •  

                    345,708

                  • +0.15%

                  • 0.44

                  • Guggenheim Capital LLC

                  •  

                    328,362

                  • +1.47%

                  • 0.42

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Distressed

                  Style

                  -

                  Organovo Holdings Inc is incorporated in Delaware on April 2007. The Company is a development-stage company. It is engaged in developing and commercializing functional human tissues that can be employed in drug discovery and developm...moreent, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The Company intend to introduce a paradigm shift in the approach to the generation of three-dimensional human tissues, by utilizing its proprietary platform technology to create human tissue constructs in 3D that mimic native human tissue composition and architecture. The Company is subject to various laws and regulations relating to safe working conditions, laboratory and manufacturing practices, the experimental use of animals, emissions and wastewater...more discharges, and the use and disposal of hazardous or potentially hazardous substances used in connection with research, including infectious disease agents.lessless

                  Key People

                  Mr. Keith Murphy

                  President/CEO/Director/Chairman of the Board

                  Barry D. Michaels

                  CFO/Secretary

                  Dr. Sharon Presnell,PhD

                  Chief Technology Officer/Executive VP, Divisional

                  Mr. Michael Renard

                  Executive VP, Divisional

                  James T. Glover

                  Director

                  • Organovo Holdings Inc

                  • 6275 Nancy Ridge Drive

                  • San Diego, CA 92121

                  • USA.Map

                  • Phone: +1 858 550-9994

                  • Fax: -

                  • organovo.com

                  Incorporated

                  2007

                  Employees

                  36

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: